nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Progesterone—uterine cancer	0.187	0.242	CbGbCtD
Saxagliptin—ABCC1—Dactinomycin—uterine cancer	0.149	0.192	CbGbCtD
Saxagliptin—ABCC1—Epirubicin—uterine cancer	0.108	0.139	CbGbCtD
Saxagliptin—ABCC1—Etoposide—uterine cancer	0.0838	0.108	CbGbCtD
Saxagliptin—CYP3A5—Progesterone—uterine cancer	0.0695	0.0898	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—uterine cancer	0.0572	0.074	CbGbCtD
Saxagliptin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0409	0.0529	CbGbCtD
Saxagliptin—CYP3A5—Etoposide—uterine cancer	0.0311	0.0402	CbGbCtD
Saxagliptin—CYP3A4—Progesterone—uterine cancer	0.0271	0.035	CbGbCtD
Saxagliptin—CYP3A4—Etoposide—uterine cancer	0.0121	0.0157	CbGbCtD
Saxagliptin—CYP3A4—Doxorubicin—uterine cancer	0.00827	0.0107	CbGbCtD
Saxagliptin—DPP8—myometrium—uterine cancer	0.00734	0.0633	CbGeAlD
Saxagliptin—DPP9—decidua—uterine cancer	0.00598	0.0515	CbGeAlD
Saxagliptin—DPP8—uterine cervix—uterine cancer	0.00571	0.0492	CbGeAlD
Saxagliptin—DPP4—exocrine gland—uterine cancer	0.00556	0.048	CbGeAlD
Saxagliptin—DPP8—smooth muscle tissue—uterine cancer	0.00555	0.0479	CbGeAlD
Saxagliptin—DPP8—decidua—uterine cancer	0.00544	0.0469	CbGeAlD
Saxagliptin—DPP8—endometrium—uterine cancer	0.00517	0.0445	CbGeAlD
Saxagliptin—DPP8—mammalian vulva—uterine cancer	0.005	0.0431	CbGeAlD
Saxagliptin—Pancreatitis acute—Progesterone—uterine cancer	0.00471	0.0425	CcSEcCtD
Saxagliptin—DPP9—female gonad—uterine cancer	0.00428	0.0369	CbGeAlD
Saxagliptin—Pancreatitis acute—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.0385	CcSEcCtD
Saxagliptin—DPP8—female gonad—uterine cancer	0.0039	0.0336	CbGeAlD
Saxagliptin—DPP8—vagina—uterine cancer	0.00387	0.0334	CbGeAlD
Saxagliptin—SLCO4C1—renal system—uterine cancer	0.00338	0.0292	CbGeAlD
Saxagliptin—SLCO4C1—endometrium—uterine cancer	0.00327	0.0282	CbGeAlD
Saxagliptin—SLCO4C1—mammalian vulva—uterine cancer	0.00316	0.0273	CbGeAlD
Saxagliptin—DPP9—lymph node—uterine cancer	0.00275	0.0237	CbGeAlD
Saxagliptin—DPP8—lymph node—uterine cancer	0.0025	0.0216	CbGeAlD
Saxagliptin—SLCO4C1—vagina—uterine cancer	0.00245	0.0211	CbGeAlD
Saxagliptin—DPP4—epithelium—uterine cancer	0.00242	0.0209	CbGeAlD
Saxagliptin—DPP4—uterine cervix—uterine cancer	0.0024	0.0207	CbGeAlD
Saxagliptin—DPP4—smooth muscle tissue—uterine cancer	0.00233	0.0201	CbGeAlD
Saxagliptin—DPP4—decidua—uterine cancer	0.00229	0.0197	CbGeAlD
Saxagliptin—DPP4—renal system—uterine cancer	0.00225	0.0194	CbGeAlD
Saxagliptin—DPP4—endometrium—uterine cancer	0.00217	0.0187	CbGeAlD
Saxagliptin—DPP4—mammalian vulva—uterine cancer	0.0021	0.0181	CbGeAlD
Saxagliptin—DPP4—uterus—uterine cancer	0.002	0.0172	CbGeAlD
Saxagliptin—DPP4—female reproductive system—uterine cancer	0.0018	0.0155	CbGeAlD
Saxagliptin—Gastroenteritis—Progesterone—uterine cancer	0.00178	0.0161	CcSEcCtD
Saxagliptin—ABCC1—myometrium—uterine cancer	0.00174	0.015	CbGeAlD
Saxagliptin—Purpura—Progesterone—uterine cancer	0.00164	0.0148	CcSEcCtD
Saxagliptin—DPP4—female gonad—uterine cancer	0.00164	0.0141	CbGeAlD
Saxagliptin—DPP4—vagina—uterine cancer	0.00163	0.014	CbGeAlD
Saxagliptin—Opportunistic infection—Epirubicin—uterine cancer	0.00155	0.014	CcSEcCtD
Saxagliptin—Face oedema—Progesterone—uterine cancer	0.00152	0.0138	CcSEcCtD
Saxagliptin—Purpura—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0134	CcSEcCtD
Saxagliptin—SLC22A8—renal system—uterine cancer	0.00148	0.0127	CbGeAlD
Saxagliptin—Infection—Carboplatin—uterine cancer	0.00147	0.0132	CcSEcCtD
Saxagliptin—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0132	CcSEcCtD
Saxagliptin—Opportunistic infection—Doxorubicin—uterine cancer	0.00143	0.0129	CcSEcCtD
Saxagliptin—Nasopharyngitis—Progesterone—uterine cancer	0.00141	0.0127	CcSEcCtD
Saxagliptin—Gastritis—Progesterone—uterine cancer	0.0014	0.0126	CcSEcCtD
Saxagliptin—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.0125	CcSEcCtD
Saxagliptin—ABCC1—uterine cervix—uterine cancer	0.00136	0.0117	CbGeAlD
Saxagliptin—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.0121	CcSEcCtD
Saxagliptin—ABCC1—decidua—uterine cancer	0.00129	0.0111	CbGeAlD
Saxagliptin—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0115	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Progesterone—uterine cancer	0.00127	0.0114	CcSEcCtD
Saxagliptin—ABCC1—endometrium—uterine cancer	0.00123	0.0106	CbGeAlD
Saxagliptin—Lymphopenia—Epirubicin—uterine cancer	0.00122	0.011	CcSEcCtD
Saxagliptin—Infestation—Progesterone—uterine cancer	0.00122	0.011	CcSEcCtD
Saxagliptin—Infestation NOS—Progesterone—uterine cancer	0.00122	0.011	CcSEcCtD
Saxagliptin—ABCC1—mammalian vulva—uterine cancer	0.00119	0.0102	CbGeAlD
Saxagliptin—Urinary tract infection—Progesterone—uterine cancer	0.00118	0.0107	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.0104	CcSEcCtD
Saxagliptin—Sinusitis—Progesterone—uterine cancer	0.00114	0.0103	CcSEcCtD
Saxagliptin—ABCC1—uterus—uterine cancer	0.00113	0.00975	CbGeAlD
Saxagliptin—Lymphopenia—Doxorubicin—uterine cancer	0.00113	0.0102	CcSEcCtD
Saxagliptin—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00995	CcSEcCtD
Saxagliptin—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00995	CcSEcCtD
Saxagliptin—Oedema peripheral—Progesterone—uterine cancer	0.00108	0.00971	CcSEcCtD
Saxagliptin—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00967	CcSEcCtD
Saxagliptin—DPP4—lymph node—uterine cancer	0.00105	0.00907	CbGeAlD
Saxagliptin—CYP3A5—uterine cervix—uterine cancer	0.00104	0.00899	CbGeAlD
Saxagliptin—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00103	0.00934	CcSEcCtD
Saxagliptin—Immune system disorder—Progesterone—uterine cancer	0.000986	0.0089	CcSEcCtD
Saxagliptin—CYP3A5—renal system—uterine cancer	0.000976	0.00841	CbGeAlD
Saxagliptin—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000975	0.0088	CcSEcCtD
Saxagliptin—Malnutrition—Progesterone—uterine cancer	0.00095	0.00858	CcSEcCtD
Saxagliptin—Flatulence—Progesterone—uterine cancer	0.000937	0.00846	CcSEcCtD
Saxagliptin—ABCC1—female gonad—uterine cancer	0.000925	0.00797	CbGeAlD
Saxagliptin—ABCC1—vagina—uterine cancer	0.00092	0.00793	CbGeAlD
Saxagliptin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000894	0.00807	CcSEcCtD
Saxagliptin—Angioedema—Progesterone—uterine cancer	0.000868	0.00784	CcSEcCtD
Saxagliptin—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000861	0.00778	CcSEcCtD
Saxagliptin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000849	0.00766	CcSEcCtD
Saxagliptin—Arthralgia—Progesterone—uterine cancer	0.000809	0.00731	CcSEcCtD
Saxagliptin—Myalgia—Progesterone—uterine cancer	0.000809	0.00731	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000804	0.00726	CcSEcCtD
Saxagliptin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000787	0.00711	CcSEcCtD
Saxagliptin—Anaphylactic shock—Progesterone—uterine cancer	0.000776	0.007	CcSEcCtD
Saxagliptin—Infection—Progesterone—uterine cancer	0.000771	0.00696	CcSEcCtD
Saxagliptin—Skin disorder—Progesterone—uterine cancer	0.000753	0.0068	CcSEcCtD
Saxagliptin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00662	CcSEcCtD
Saxagliptin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000733	0.00662	CcSEcCtD
Saxagliptin—CYP3A4—renal system—uterine cancer	0.000732	0.00631	CbGeAlD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00658	CcSEcCtD
Saxagliptin—CYP3A5—female gonad—uterine cancer	0.000711	0.00613	CbGeAlD
Saxagliptin—CYP3A5—vagina—uterine cancer	0.000707	0.00609	CbGeAlD
Saxagliptin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000707	0.00638	CcSEcCtD
Saxagliptin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000703	0.00635	CcSEcCtD
Saxagliptin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00631	CcSEcCtD
Saxagliptin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000688	0.00621	CcSEcCtD
Saxagliptin—Dyspepsia—Progesterone—uterine cancer	0.000683	0.00617	CcSEcCtD
Saxagliptin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000683	0.00616	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00067	0.00605	CcSEcCtD
Saxagliptin—Fatigue—Progesterone—uterine cancer	0.000669	0.00604	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00064	0.00578	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Progesterone—uterine cancer	0.000634	0.00573	CcSEcCtD
Saxagliptin—Infestation NOS—Etoposide—uterine cancer	0.000622	0.00562	CcSEcCtD
Saxagliptin—Infestation—Etoposide—uterine cancer	0.000622	0.00562	CcSEcCtD
Saxagliptin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.00559	CcSEcCtD
Saxagliptin—Urticaria—Progesterone—uterine cancer	0.000616	0.00556	CcSEcCtD
Saxagliptin—Abdominal pain—Progesterone—uterine cancer	0.000613	0.00554	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000607	0.00548	CcSEcCtD
Saxagliptin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000606	0.00547	CcSEcCtD
Saxagliptin—ABCC1—lymph node—uterine cancer	0.000595	0.00513	CbGeAlD
Saxagliptin—CYP3A4—female reproductive system—uterine cancer	0.000586	0.00505	CbGeAlD
Saxagliptin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00519	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—uterine cancer	0.000572	0.00516	CcSEcCtD
Saxagliptin—Hypersensitivity—Progesterone—uterine cancer	0.000571	0.00516	CcSEcCtD
Saxagliptin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000558	0.00504	CcSEcCtD
Saxagliptin—Asthenia—Progesterone—uterine cancer	0.000557	0.00503	CcSEcCtD
Saxagliptin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00502	CcSEcCtD
Saxagliptin—Pruritus—Progesterone—uterine cancer	0.000549	0.00496	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—uterine cancer	0.000545	0.00492	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000537	0.00485	CcSEcCtD
Saxagliptin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000518	0.00468	CcSEcCtD
Saxagliptin—Dizziness—Progesterone—uterine cancer	0.000513	0.00463	CcSEcCtD
Saxagliptin—Immune system disorder—Etoposide—uterine cancer	0.000504	0.00456	CcSEcCtD
Saxagliptin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00455	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000499	0.00451	CcSEcCtD
Saxagliptin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000497	0.00449	CcSEcCtD
Saxagliptin—Vomiting—Progesterone—uterine cancer	0.000493	0.00445	CcSEcCtD
Saxagliptin—Rash—Progesterone—uterine cancer	0.000489	0.00442	CcSEcCtD
Saxagliptin—Dermatitis—Progesterone—uterine cancer	0.000489	0.00441	CcSEcCtD
Saxagliptin—Headache—Progesterone—uterine cancer	0.000486	0.00439	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—uterine cancer	0.000473	0.00427	CcSEcCtD
Saxagliptin—Purpura—Epirubicin—uterine cancer	0.00047	0.00424	CcSEcCtD
Saxagliptin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000465	0.0042	CcSEcCtD
Saxagliptin—Hypoglycaemia—Epirubicin—uterine cancer	0.000464	0.00419	CcSEcCtD
Saxagliptin—Nausea—Progesterone—uterine cancer	0.000461	0.00416	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000448	0.00405	CcSEcCtD
Saxagliptin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000447	0.00404	CcSEcCtD
Saxagliptin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.004	CcSEcCtD
Saxagliptin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.004	CcSEcCtD
Saxagliptin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00044	0.00398	CcSEcCtD
Saxagliptin—Face oedema—Epirubicin—uterine cancer	0.000437	0.00394	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—uterine cancer	0.000434	0.00392	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—uterine cancer	0.000433	0.00391	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—uterine cancer	0.000429	0.00387	CcSEcCtD
Saxagliptin—Blood creatinine increased—Epirubicin—uterine cancer	0.000424	0.00383	CcSEcCtD
Saxagliptin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000417	0.00377	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000411	0.00371	CcSEcCtD
Saxagliptin—Nasopharyngitis—Epirubicin—uterine cancer	0.000405	0.00365	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—uterine cancer	0.000404	0.00365	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—uterine cancer	0.000404	0.00365	CcSEcCtD
Saxagliptin—Gastritis—Epirubicin—uterine cancer	0.000401	0.00362	CcSEcCtD
Saxagliptin—Anaphylactic shock—Etoposide—uterine cancer	0.000397	0.00358	CcSEcCtD
Saxagliptin—Infection—Etoposide—uterine cancer	0.000394	0.00356	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—uterine cancer	0.000393	0.00355	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000392	0.00354	CcSEcCtD
Saxagliptin—Thrombocytopenia—Etoposide—uterine cancer	0.000389	0.00351	CcSEcCtD
Saxagliptin—Skin disorder—Etoposide—uterine cancer	0.000385	0.00348	CcSEcCtD
Saxagliptin—Pancreatitis—Epirubicin—uterine cancer	0.000383	0.00346	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—uterine cancer	0.000374	0.00338	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—uterine cancer	0.000371	0.00335	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000364	0.00328	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—uterine cancer	0.000355	0.0032	CcSEcCtD
Saxagliptin—Infestation NOS—Epirubicin—uterine cancer	0.000349	0.00315	CcSEcCtD
Saxagliptin—Infestation—Epirubicin—uterine cancer	0.000349	0.00315	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—uterine cancer	0.000349	0.00315	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—uterine cancer	0.000346	0.00312	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000343	0.00309	CcSEcCtD
Saxagliptin—Fatigue—Etoposide—uterine cancer	0.000342	0.00309	CcSEcCtD
Saxagliptin—Urinary tract infection—Epirubicin—uterine cancer	0.000339	0.00306	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000336	0.00304	CcSEcCtD
Saxagliptin—Sinusitis—Epirubicin—uterine cancer	0.000327	0.00295	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—uterine cancer	0.000326	0.00294	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Etoposide—uterine cancer	0.000324	0.00293	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—uterine cancer	0.000323	0.00291	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—uterine cancer	0.000323	0.00291	CcSEcCtD
Saxagliptin—Urticaria—Etoposide—uterine cancer	0.000315	0.00285	CcSEcCtD
Saxagliptin—Abdominal pain—Etoposide—uterine cancer	0.000314	0.00283	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—uterine cancer	0.000314	0.00283	CcSEcCtD
Saxagliptin—Oedema peripheral—Epirubicin—uterine cancer	0.000308	0.00278	CcSEcCtD
Saxagliptin—Sinusitis—Doxorubicin—uterine cancer	0.000303	0.00273	CcSEcCtD
Saxagliptin—Hypersensitivity—Etoposide—uterine cancer	0.000292	0.00264	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—uterine cancer	0.000285	0.00258	CcSEcCtD
Saxagliptin—Asthenia—Etoposide—uterine cancer	0.000285	0.00257	CcSEcCtD
Saxagliptin—Immune system disorder—Epirubicin—uterine cancer	0.000283	0.00255	CcSEcCtD
Saxagliptin—Pruritus—Etoposide—uterine cancer	0.000281	0.00253	CcSEcCtD
Saxagliptin—Malnutrition—Epirubicin—uterine cancer	0.000273	0.00246	CcSEcCtD
Saxagliptin—Flatulence—Epirubicin—uterine cancer	0.000269	0.00242	CcSEcCtD
Saxagliptin—Dizziness—Etoposide—uterine cancer	0.000262	0.00237	CcSEcCtD
Saxagliptin—Immune system disorder—Doxorubicin—uterine cancer	0.000262	0.00236	CcSEcCtD
Saxagliptin—Vomiting—Etoposide—uterine cancer	0.000252	0.00228	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—uterine cancer	0.000252	0.00228	CcSEcCtD
Saxagliptin—Rash—Etoposide—uterine cancer	0.00025	0.00226	CcSEcCtD
Saxagliptin—Dermatitis—Etoposide—uterine cancer	0.00025	0.00226	CcSEcCtD
Saxagliptin—Headache—Etoposide—uterine cancer	0.000249	0.00224	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—uterine cancer	0.000248	0.00224	CcSEcCtD
Saxagliptin—Nausea—Etoposide—uterine cancer	0.000236	0.00213	CcSEcCtD
Saxagliptin—Myalgia—Epirubicin—uterine cancer	0.000232	0.0021	CcSEcCtD
Saxagliptin—Arthralgia—Epirubicin—uterine cancer	0.000232	0.0021	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00023	0.00208	CcSEcCtD
Saxagliptin—Anaphylactic shock—Epirubicin—uterine cancer	0.000222	0.00201	CcSEcCtD
Saxagliptin—Infection—Epirubicin—uterine cancer	0.000221	0.002	CcSEcCtD
Saxagliptin—Thrombocytopenia—Epirubicin—uterine cancer	0.000218	0.00197	CcSEcCtD
Saxagliptin—Skin disorder—Epirubicin—uterine cancer	0.000216	0.00195	CcSEcCtD
Saxagliptin—Myalgia—Doxorubicin—uterine cancer	0.000215	0.00194	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—uterine cancer	0.000215	0.00194	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000213	0.00193	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000206	0.00186	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—uterine cancer	0.000204	0.00185	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000203	0.00183	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000202	0.00182	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—uterine cancer	0.0002	0.00181	CcSEcCtD
Saxagliptin—Dyspepsia—Epirubicin—uterine cancer	0.000196	0.00177	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000192	0.00173	CcSEcCtD
Saxagliptin—Fatigue—Epirubicin—uterine cancer	0.000192	0.00173	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000188	0.00169	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000182	0.00164	CcSEcCtD
Saxagliptin—Dyspepsia—Doxorubicin—uterine cancer	0.000181	0.00164	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000178	0.0016	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—uterine cancer	0.000177	0.0016	CcSEcCtD
Saxagliptin—Urticaria—Epirubicin—uterine cancer	0.000177	0.0016	CcSEcCtD
Saxagliptin—Abdominal pain—Epirubicin—uterine cancer	0.000176	0.00159	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000168	0.00152	CcSEcCtD
Saxagliptin—Hypersensitivity—Epirubicin—uterine cancer	0.000164	0.00148	CcSEcCtD
Saxagliptin—Urticaria—Doxorubicin—uterine cancer	0.000163	0.00148	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—uterine cancer	0.000163	0.00147	CcSEcCtD
Saxagliptin—Asthenia—Epirubicin—uterine cancer	0.00016	0.00144	CcSEcCtD
Saxagliptin—Pruritus—Epirubicin—uterine cancer	0.000157	0.00142	CcSEcCtD
Saxagliptin—Hypersensitivity—Doxorubicin—uterine cancer	0.000152	0.00137	CcSEcCtD
Saxagliptin—Asthenia—Doxorubicin—uterine cancer	0.000148	0.00133	CcSEcCtD
Saxagliptin—Dizziness—Epirubicin—uterine cancer	0.000147	0.00133	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—uterine cancer	0.000146	0.00131	CcSEcCtD
Saxagliptin—Vomiting—Epirubicin—uterine cancer	0.000141	0.00128	CcSEcCtD
Saxagliptin—Rash—Epirubicin—uterine cancer	0.00014	0.00127	CcSEcCtD
Saxagliptin—Dermatitis—Epirubicin—uterine cancer	0.00014	0.00127	CcSEcCtD
Saxagliptin—Headache—Epirubicin—uterine cancer	0.000139	0.00126	CcSEcCtD
Saxagliptin—Dizziness—Doxorubicin—uterine cancer	0.000136	0.00123	CcSEcCtD
Saxagliptin—Nausea—Epirubicin—uterine cancer	0.000132	0.00119	CcSEcCtD
Saxagliptin—Vomiting—Doxorubicin—uterine cancer	0.000131	0.00118	CcSEcCtD
Saxagliptin—Rash—Doxorubicin—uterine cancer	0.00013	0.00117	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—uterine cancer	0.00013	0.00117	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—uterine cancer	0.000129	0.00116	CcSEcCtD
Saxagliptin—Nausea—Doxorubicin—uterine cancer	0.000122	0.0011	CcSEcCtD
